Last reviewed · How we verify
Huazhi Rougan Granule Placebo granule
This is a placebo granule formulation with no active pharmaceutical ingredient and therefore no mechanistic action.
This is a placebo granule formulation with no active pharmaceutical ingredient and therefore no mechanistic action. Used for Clinical trial control comparator (non-therapeutic use).
At a glance
| Generic name | Huazhi Rougan Granule Placebo granule |
|---|---|
| Sponsor | Shandong New Time Pharmaceutical Co., LTD |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a placebo product, Huazhi Rougan Granule Placebo contains no active drug substance and produces no pharmacological effect. It is used as a control comparator in clinical trials to assess the efficacy of active treatments through comparison against inert formulations. Placebo granules may produce perceived clinical benefits through the placebo effect but have no direct molecular or physiological mechanism of action.
Approved indications
- Clinical trial control comparator (non-therapeutic use)
Common side effects
Key clinical trials
- Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis (NA)
- A Phase IV Study of Huazhi Rougan Granule (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: